Solara Active Pharma Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

36.00

36.00

35.92

26.85

25.77

Share application money

1.05

-

-

96.00

104.00

Preference share capital

-

-

-

-

-

Reserves & surplus

1,466.08

1,491.05

1,556.86

967.94

835.96

Loan funds

Secured loans

1,001.15

1,024.57

515.71

586.50

439.43

Unsecured loans

-

-

-

-

-

Total

2,504.28

2,551.62

2,108.49

1,677.29

1,405.16

Uses of funds

Fixed assets

Gross block

1,781.20

1,683.07

1,625.90

1,549.36

1,189.27

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

439.19

348.92

266.89

175.27

89.65

Net block

1,342.01

1,334.15

1,359.01

1,374.09

1,099.62

Capital work-in-progress

238.47

238.65

87.72

40.21

33.65

Investments

16.05

18.13

18.13

18.03

149.13

Net current assets

Current assets, loans & advances

1,298.42

1,358.74

1,145.31

719.28

652.41

Less : current liabilities & provisions

390.67

398.05

501.68

474.32

529.65

Total net current assets

907.75

960.69

643.63

244.96

122.76

Miscellaneous expenses not written

-

-

-

-

-

Total

2,504.28

2,551.62

2,108.49

1,677.29

1,405.16

Notes:

Book value of unquoted investments

16.05

17.71

18.13

18.03

149.13

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

38.00

66.88

104.50

73.51

95.73

Number of equity sharesoutstanding (Lacs)

359.96

359.96

359.30

268.55

257.74